Neuroendocrine tumors (NETs) are a rare and complex form of cancer that can affect various organs in the body, including the pancreas, lungs, and digestive tract. Despite its rarity, neuroendocrine cancer is becoming increasingly prevalent, and the demand for specialized care is growing. In this blog, we’ll explore the Neuroendocrine Cancer Program at Penn Medicine and how it offers patients access to expert care in one of the country’s leading cancer subspecialties.
Understanding Neuroendocrine Cancer
Neuroendocrine tumors are a type of cancer that arise from cells in the endocrine system, which produces hormones that regulate various bodily functions. These tumors can be benign or malignant and can occur anywhere in the body, but are most commonly found in the pancreas, lungs, and digestive tract.
The Neuroendocrine Cancer Program at Penn Medicine
The Neuroendocrine Cancer Program at Penn Medicine is a comprehensive program that offers patients access to a multidisciplinary team of experts, including medical oncologists, surgical oncologists, radiation oncologists, and gastroenterologists. The program provides patients with a personalized treatment plan based on their specific needs and the location and stage of their tumor.
Advanced Diagnostic and Treatment Options
The Neuroendocrine Cancer Program at Penn Medicine offers advanced diagnostic and treatment options, including:
- Endoscopic ultrasound (EUS) and octreotide scans to locate tumors
- Minimally invasive surgery to remove tumors
- Peptide receptor radionuclide therapy (PRRT) to treat metastatic tumors
- Chemotherapy and radiation therapy for advanced cases
- Clinical trials for new and innovative treatments
Collaborative Care
The Neuroendocrine Cancer Program at Penn Medicine emphasizes collaborative care, with specialists from various disciplines working together to provide the best possible care for each patient. The team regularly meets to discuss each patient’s case, ensuring that the treatment plan is tailored to their specific needs and that they receive the highest level of care.
Penn Medicine vs Cleveland Clinic’s Taussig Cancer Center
While there are many cancer centers across the country, the Neuroendocrine Cancer Program at Penn Medicine stands out for its multidisciplinary approach and access to advanced diagnostic and treatment options. Cleveland Clinic’s Taussig Cancer Center also offers specialized care in neuroendocrine tumors, with a dedicated multidisciplinary team and access to clinical trials. However, patients may choose Penn Medicine for its location in Philadelphia, a hub for medical research and innovation.
Conclusion
Neuroendocrine cancer is a rare and complex form of cancer that requires specialized care. The Neuroendocrine Cancer Program at Penn Medicine offers patients access to a multidisciplinary team of experts and advanced diagnostic and treatment options to provide the best possible care. With its emphasis on collaborative care and personalized treatment plans, the Neuroendocrine Cancer Program at Penn Medicine is a leading choice for patients seeking specialized care in neuroendocrine tumors.
